Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | GBA1 | P04062 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 2-Methoxyethanol SCHEMBL145211 | 1.00 | TSHR (0.41) | TSHRMAPK1ALDH1A1MEN1KMT2A | |
| 2-Methoxyethanol SCHEMBL2915239 | 1.00 | TSHR (0.41) | TSHRMAPK1ALDH1A1MEN1KMT2A | |
| 2-Methoxyethanol SCHEMBL19086860 | 1.00 | TSHR (0.41) | TSHRMAPK1ALDH1A1MEN1KMT2A | |
| 2-Methoxyethanol SCHEMBL17351933 | 1.00 | TSHR (0.41) | TSHRMAPK1ALDH1A1MEN1KMT2A | |
| 2-Methoxyethanol SCHEMBL3548931 | 1.00 | TSHR (0.41) | TSHRMAPK1ALDH1A1MEN1KMT2A | |
| 2-Methoxyethanol SCHEMBL1482714 | 1.00 | — | — | |
| 2-Methoxyethanol SCHEMBL17351943 | 1.00 | TSHR (0.41) | TSHRMAPK1ALDH1A1MEN1KMT2A | |
| 2-Methoxyethanol SCHEMBL6268627 | 1.00 | TSHR (0.41) | TSHRMAPK1ALDH1A1MEN1KMT2A | |
| 2-Methoxyethanol SCHEMBL21641729 | 1.00 | TSHR (0.41) | TSHRMAPK1ALDH1A1MEN1KMT2A | |
| 2-Methoxyethanol SCHEMBL5091016 | 1.00 | TSHR (0.41) | TSHRMAPK1ALDH1A1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 229 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250218698-A1 | ELECTROLYTIC CAPACITOR | PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) | 2025-07-03 | — | — | US | claimed |
| CN-119663399-A | Pre-hole sealing treatment liquid and pre-hole sealing treatment method | 深圳市鑫鸿达清洗技术有限公司 | 2025-03-21 | — | — | CN | claimed |
| CN-118974864-A | Electrolytic capacitor | 松下知识产权经营株式会社 | 2024-11-15 | — | — | CN | claimed |
| CN-113248352-B | Method for synthesizing heptaglyme through solid phase | 长沙创新药物工业技术研究院有限公司 | 2024-08-13 | — | — | CN | claimed |
| CN-118086986-A | High-coverage electroplated copper additive composition for printed circuit board | 广东利尔化学有限公司 | 2024-05-28 | — | — | CN | claimed |
| WO-2023190203-A1 | ELECTROLYTIC CAPACITOR | パナソニックＩＰマネジメント株式会社 | 2023-10-05 | — | — | WO | claimed |
| CN-114158567-A | Iodine-containing disinfectant containing hydroxyl-containing polyol ether and preparation method and application thereof | 佛山市正典生物技术有限公司 | 2022-03-11 | — | — | CN | claimed |
| CN-113248352-A | Method for solid-phase synthesis of heptaethylene glycol monomethyl ether | 湖南华腾制药有限公司 | 2021-08-13 | — | — | CN | claimed |
| CN-112898452-A | Hydrophilic antifogging polyolefin material and preparation method and application thereof | 中国科学院化学研究所 | 2021-06-04 | — | — | CN | claimed |
| US-20150367277-A1 | Alkanolamine-Based Carbon Dioxide Absorbent Containing Polyalkylene Glycol Monomethyl Ether, and Carbon Dioxide Absorption Method and Separation Method Using Same | UNIVERSITY-INDUSTRY COOPERATION FOUNDATION OF KYUNG HEE UNIVERSITY (KR) | 2015-12-24 | — | — | US | claimed |
| JP-2004523559-A | — | — | 2004-08-05 | — | — | JP | claimed |
| EP-1372661-A2 | METHODS OF TREATING IRRITABLE BOWEL SYNDROME AND FUNCTIONAL DYSPEPSIA | SmithKline Beecham Corporation (US) | 2004-01-02 | — | — | EP | claimed |
| WO-2002067942-A2 | METHODS OF TREATING IRRITABLE BOWEL SYNDROME AND FUNCTIONAL DYSPEPSIA | SMITHKLINE BEECHAM CORPORATION (US) | 2002-09-06 | — | — | WO | claimed |
| US-20260147276-A1 | NEGATIVE RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2026-05-28 | — | — | US | disclosed |
| US-20260147277-A1 | TRANSFER FILM, PATTERN FORMING METHOD, LAMINATE, AND SEMICONDUCTOR PACKAGE | FUJIFILM CORPORATION (JP) | 2026-05-28 | — | — | US | disclosed |
| US-12637441-B2 | Prodrugs of the tyrosine kinase inhibitor for treating cancer | Risen (Suzhou) Pharma Tech Co., Ltd. (CN) | 2026-05-26 | — | — | US | disclosed |
| US-5954891-A | ANTISOILANTS OF NONIONIC DETERGENTS ADHERED USING THE DETERGENT COMPOSITION AS DEFINED IN CLAIM 1 OR 2; | KAO CORPORATION (JP) | 1999-09-21 | — | — | US | disclosed |
| EP-0853116-A1 | Detergent composition for removing resinous stains | KAO CORPORATION (JP) | 1998-07-15 | — | — | EP | disclosed |
| US-4407810-A | TREATMENT OF ALLERGIC DISORDERS | BASF AKTIENGESELLSCHAFT (DE) | 1983-10-04 | — | — | US | disclosed |
| US-3972949-A | Process for preparing glycol dimethyl ethers | HOECHST AKTIENGESELLSCHAFT (DT) | 1976-08-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260147276-A1 | NEGATIVE RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN | RFC1, RFC2, RFC4 | TSHR 4670/4885MAPK1 1962/4885ALDH1A1 2990/4885 |
| US-20260147277-A1 | TRANSFER FILM, PATTERN FORMING METHOD, LAMINATE, AND SEMICONDUCTOR PACKAGE | LCP1, PCNA, FDFT1 | TSHR 3691/4885MAPK1 3368/4885ALDH1A1 3998/4885 |
| US-12637441-B2 | Prodrugs of the tyrosine kinase inhibitor for treating cancer | EGFR, ERBB2, MET | TSHR 391/4885MAPK1 273/4885ALDH1A1 3172/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.